Business
Following Stockholder Approval, BIO-key Announces 1-for-10 Reverse Stock Split
HOLMDEL, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced that it has approved a 1-for-10 reverse stock split that will become effective with the commencement of trading on April 30, 2026. BIO-key stockholders approved a proposal last week to allow the Board to proceed with a reverse split to assist the Company in its effort to regain compliance
About this update from Bio-key International, Inc.
[{"type":"image","alt":"BIO-key International, Inc.","displaySize":"","headline":null,"caption":"BIO-key International, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":169,"url":"https://media.zenfs.com/en/globenewswire.com/94a8d3cbec770ac8055020cd853d1013"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pDacC.czWUYH8YWAl50fwQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIzNw--/https://media.zenfs.com/en/globenewswire.com/94a8d3cbec770ac8055020cd853d1013","width":300,"height":169}},"lazy":false},{"type":"text","content":"HOLMDEL, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced that it has approved a 1-for-10 reverse stock split that will become effective with the commencement of trading on April 30, 2026.","length":340,"tagName":"p"},{"type":"text","content":"BIO-key stockholders approved a proposal last week to allow the Board to proceed with a reverse split to assist the Company in its effort to regain compliance with the minimum bid price requirement.","length":198,"tagName":"p"},{"type":"text","content":"BIO-key had approximately 10.9 million shares of common stock issued and outstanding as of April 28, 2026. After giving effect to the 1-for-10 reverse stock split, BIO-key will have approximately 1.1 million shares of common stock issued and outstanding.","length":254,"tagName":"p"},{"type":"text","content":"BIO-key CEO Michael DePasquale commented, “The Board’s decision to set the ratio at 1-for-10 was intended to position our common stock for minimum bid price compliance as we execute on our growth goals, including profitability in the first half of 2026.”","length":254,"tagName":"p"},{"type":"text","content":"About BIO-key International, Inc. (www.BIO-key.com)BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applicati...